enfuvirtide and maleimide

enfuvirtide has been researched along with maleimide* in 1 studies

Other Studies

1 other study(ies) available for enfuvirtide and maleimide

ArticleYear
Design and synthesis of alpha Gal-conjugated peptide T20 as novel antiviral agent for HIV-immunotargeting.
    Organic & biomolecular chemistry, 2004, Mar-07, Volume: 2, Issue:5

    An efficient chemo-enzymatic synthesis of alpha Gal-conjugated peptide T20 as novel HIV-immuno-targeting agent is described. The synthesis involves chemo-enzymatic preparation of maleimide-functionalized alpha Gal epitope and its chemoselective ligation with the peptide T20. The title compound contains two functional domains: the trisaccharide alpha Gal epitope that binds to human natural anti-Gal antibodies and the 36-amino acid gp41 peptide (T20) that recognizes the gp41 N-terminal ectodomain of the HIV envelope. Biological assays demonstrated that the synthetic conjugate could readily bind to natural anti-Gal antibodies (both IgG and IgM type) in normal human serum and exhibited potent anti-HIV activity even in the absence of human antibodies and complement system. The experimental data suggest that the synthetic alpha Gal-T20 might be valuable for in vivo HIV-immuno-targeting via antibody-mediated cytotoxicity and/or antibody-dependent, complement-mediated lysis of HIV particles and HIV-infected cells, thus providing an additional dimension of HIV intervention.

    Topics: Anti-HIV Agents; Carbohydrate Sequence; Drug Design; Enfuvirtide; Galactose; HIV Envelope Protein gp41; HIV-1; Humans; Laminin; Maleimides; Molecular Sequence Data; Monocytes; Peptide Fragments; Trisaccharides

2004